Is there a place for F18-FDG PET/CT in the diagnosis o f primary breast cancer?

被引:1
|
作者
Morariu, Dragos Stefan [1 ,2 ]
Vlad, Catalin [1 ,2 ]
Puscas, Marius Emil [1 ,2 ]
Gata, Vlad [1 ,2 ]
Piciu, Doina [1 ,3 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania
[2] Oncol Inst Prof Dr Ion Chiricuta, Dept Surg Oncol, Cluj Napoca, Romania
[3] Oncol Inst Prof Dr Ion Chiricuta, Dept Nucl Med, Cluj Napoca, Romania
来源
JOURNAL OF BUON | 2020年 / 25卷 / 02期
关键词
breast cancer; F18; FDG; imaging technique; MRI; PET-CT; POSITRON-EMISSION-TOMOGRAPHY; HIGH FAMILIAL RISK; NEOADJUVANT CHEMOTHERAPY; FDG-PET/CT; MAMMOGRAPHY; MRI; WOMEN; ULTRASOUND; ACCURACY; US;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: With the improvement of techniques and the update of diagnostic protocols in breast cancer, modern imaging proves to be effective in the diagnosis of this pathology, as well as in its prognosis. This study aimed to evaluate the effectiveness of these modern imaging techniques through a systematic assessment of the most recent studies. Methods: A PUBMED search, using certain key combinations ("breast cancer", "F18 FDG PET-CT", "MRI", "staging", "diagnosis") and some inclusion and exclusion criteria, yielded 24 articles published during 2014-2018. Results: Using these 24 articles, the various statistical tests showed a significant difference between modern imaging techniques, with respect to prognosis (p<0.05), in close correlation with the immunohistochemical profile of the tumor. Conclusions: Modern imaging techniques (F18-FDG/PET-CT, F18-FDG/PET-MRI) were validated to formulate a better prognostic value than conventional imaging, presenting a sustainable higher sensitivity and specificity in evidencing the locoregional invasion and the recurrence of this pathology.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [1] Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer
    Araz, M.
    Soydal, C.
    Dursun, E.
    Mesci, I.
    Konca, C.
    Ozkan, E.
    Kir, M. K.
    Kucuk, N. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S17 - S17
  • [2] Clinical Usefulness of F18-FDG PET/CT in Young Patients with Breast Cancer
    Jois, Abhiram
    Parghane, Rahul
    Sood, Ashwani
    Bhattacharya, Anish
    Mittal, Bhagwant
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [3] F18-FDG PET/CT for detection of recurrent endometrial cancer
    Lebron, Lizza
    Ma, Weining
    Larson, Steven M.
    Pandit-Taskar, Neeta
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [4] SUBCUTANEOUS F18-FDG PET/CT UPTAKE
    Khan, S.
    Lin, M.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 41 - 41
  • [5] Comparative studies PEM and PET-CT for breast cancer diagnostic with F18-FDG
    Sanchez Jurado, R.
    Ferrer Rebolleda, J.
    Cozar Santiago, M.
    Devis Saiz, M.
    Aguilar Barrios, J.
    Martinez Alonso, P.
    Vicedo Gonzalez, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S249 - S250
  • [6] F18-FDG PET/CT in primary malignant melanoma of the cervix uteri
    Pernthaler, B.
    Nazerani-Zemann, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S891 - S892
  • [7] PET/CT with F18-FDG initial staging in patients with esophageal cancer
    Marti Samper, Alejandro
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2016, 20 (03): : 141 - 145
  • [8] Hibernoma: Intense Uptake on F18-FDG PET/CT
    Jong Deok Kim
    Hang Woo Lee
    Nuclear Medicine and Molecular Imaging, 2012, 46 (3) : 218 - 222
  • [9] Unusual Urethral F18-FDG Accumulation on PET/CT
    Kavak, Kevser
    Aydin, Mehmet
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (01) : 57 - 58
  • [10] F18-FDG PET/CT in a patient with Antisynthetase Syndrome
    Nazerani-Zemann, Tina
    Stanzel, Susanne
    Gstettner, Christian
    Aigner, Reingard Maria
    Pernthaler, Birgit
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2023, 62 (02): : 73 - 74